6.5 Discussion Questions
1. Who are the main stakeholders in this case, and what are their primary interests?
2. What is the ethical rationale for allowing or not allowing medical students who are MRSA carriers to continue their medical education?
3. What would be your ethical justification for either recommending or not recommending universal screening for all medical students and doctors?
4. How would it change your recommendation if
(a) The MRSA of this student was not PVL positive?
(b) The overall prevalence of MRSA in the Netherlands was high or rapidly increasing?
(c) There was little or no evidence that excluding colonized health care workers decrease risks to patients?
(d) The students agreed to pursue medical specialties that do not involve patient care?
5. Although the European Union (EU) is increasingly standardizing its AMR policy, some EU countries have less stringent regulations than others. Would it be ethical to advise the medical students in question to finish their education in a European country with a less stringent MRSA policy?
